This study showed that the radiomics nomogram model based on rad-score and clinical-imaging features (tumor margin and enhancement pattern) exhibits optimal performance in predicting the CD8+TILs levels in HER2-positive BC. This evidence concerns the gene ERBB2 and breast cancer.